Drugging the PI3 kinome
作者： Paul Workman , Paul A Clarke , Sandrine Guillard , Florence I Raynaud
DOI: 10.1038/NBT0706-794
关键词:
摘要: technology to select for DARPins with novel binding specificities. However, like thioredoxin, cannot be efficiently exported the periplasm using signal sequences encoded in commonly available cloning vectors, such as PhoA sequence, a model sequence that has been extensively studied, and PelB found many pET vectors (
nature.com
core.ac.uk
sci-hub.se 参考文章(11)
Dos D Sarbassov, David A Guertin, Siraj M Ali, David M Sabatini, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science. ,vol. 307, pp. 1098- 1101 ,(2006) , 10.1126/SCIENCE.1106148
Lazaros C. Foukas, Marc Claret, Wayne Pearce, Klaus Okkenhaug, Stephen Meek, Emma Peskett, Sara Sancho, Andrew J. H. Smith, Dominic J. Withers, Bart Vanhaesebroeck, Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation Nature. ,vol. 441, pp. 366- 370 ,(2006) , 10.1038/NATURE04694
Jianhua Feng, Jongsun Park, Peter Cron, Daniel Hess, Brian A. Hemmings, Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase Journal of Biological Chemistry. ,vol. 279, pp. 41189- 41196 ,(2004) , 10.1074/JBC.M406731200
Qi-Wen Fan, Zachary A. Knight, David D. Goldenberg, Wei Yu, Keith E. Mostov, David Stokoe, Kevan M. Shokat, William A. Weiss, A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma Cancer Cell. ,vol. 9, pp. 341- 349 ,(2006) , 10.1016/J.CCR.2006.03.029
Zachary A. Knight, Beatriz Gonzalez, Morri E. Feldman, Eli R. Zunder, David D. Goldenberg, Olusegun Williams, Robbie Loewith, David Stokoe, Andras Balla, Balazs Toth, Tamas Balla, William A. Weiss, Roger L. Williams, Kevan M. Shokat, A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling Cell. ,vol. 125, pp. 733- 747 ,(2006) , 10.1016/J.CELL.2006.03.035
Kathryn E O'Reilly, Fredi Rojo, Qing-Bai She, David Solit, Gordon B Mills, Debra Smith, Heidi Lane, Francesco Hofmann, Daniel J Hicklin, Dale L Ludwig, Jose Baselga, Neal Rosen, None, mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt Cancer Research. ,vol. 66, pp. 1500- 1508 ,(2006) , 10.1158/0008-5472.CAN-05-2925
Shin-ichi Yaguchi, Yasuhisa Fukui, Ichiro Koshimizu, Hisashi Yoshimi, Toshiyuki Matsuno, Hiroaki Gouda, Shuichi Hirono, Kanami Yamazaki, Takao Yamori, Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor Journal of the National Cancer Institute. ,vol. 98, pp. 545- 556 ,(2006) , 10.1093/JNCI/DJJ133
Reuben J. Shaw, Lewis C. Cantley, Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. ,vol. 441, pp. 424- 430 ,(2006) , 10.1038/NATURE04869
P. WORKMAN, Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics. Cold Spring Harbor Symposia on Quantitative Biology. ,vol. 70, pp. 499- 515 ,(2005) , 10.1101/SQB.2005.70.020
Igor Vivanco, Charles L. Sawyers, The phosphatidylinositol 3-Kinase–AKT pathway in human cancer Nature Reviews Cancer. ,vol. 2, pp. 489- 501 ,(2002) , 10.1038/NRC839